The eConsent Implementation Guide created and published by EUCROF’s eClinical Forum Electronic Informed Consent Joint Task Force has been shortlisted as a finalist in the Innovation award category at the TOPRA Awards.

Published in 2021, the guide aims to break down barriers to implementing eConsent processes in early phase research. It illustrates the efficiencies these advanced, electronic ways of working can provide to CROs, sponsors and regulators, and the benefits to volunteers. 

The pandemic emphasised the importance of discovering new, virtual processes and considers the practical implications of eConsent for all stakeholders.

Richmond Pharmacology has been actively involved in EUCROF, the European CRO Federation since its inception. Providing expert insight into medical research, the practical aspects of regulation and helping to shape the future of clinical trial industry. 

We look forward to the winner being announced during the in-person ceremony on 18th November 2021.  

You can read the guide here – eConsent Implementation Guide

Latest news

Medicines Marketing UK / EU vs US: Why Your Launch Strategy Needs a Continental Divide - Dr Lisa Campbell, Director of Regulatory Strategy

September 12, 2025
A UK CRO’s perspective on planning clinical trials for global success For pharmaceutical companies preparing for global expansion, launching in both the US and EU / UK markets often seems like the natural next step. Yet success in one region does not guarantee success in the other.
Read more

Events

JSCPT 2025

5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event